Peter Michael Rothschild is a businessperson who founded BioGaia AB and who has been at the head of 14 different companies. Presently, Mr. Rothschild holds the position of Chairman for BioGaia AB, Chairman at MetaboGen AB, Chairman for CapAble AB, Chairman at BioGaia Production AB and Chairman of BioGaia Pharma AB (which are all subsidiaries of BioGaia AB), Chairman of Looft Industries AB, Chairman of Infant Bacterial Therapeutics AB, Chairman of Twopac Laboratories AB, Chairman of Twopac Machine AB, Chairman at Atina Enterprises AB, Chairman at Voranco Holding AB, Chairman at Nefor Holding AB and Chairman of The Foundation To Prevent Antibiotic Resistance. Peter Michael Rothschild is also on the board of Perlan Dialog Ledarskap AB, TwoPac AB, Annwall & Rothschild Investments AB and Allbright and Partner at Argoinvest Kommanditbolag.
In his past career he was Chairman for TriPac AB.
Mr. Rothschild received an MBA from Stockholm School of Economics.